A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/23/2011	CN101632820B Intestinal obstruction removal pill
11/23/2011	CN101628919B Camptothecin, self-emulsifying medicine precursor of derivative thereof and application thereof
11/23/2011	CN101623447B Capsule for treating hypertension
11/23/2011	CN101612111B Sustained-release microsphere of nomegestrol acetate of analogs thereof and preparation method and application thereof
11/23/2011	CN101607014B Ointment for promoting tissue regeneration and restraining sore and preparation method thereof
11/23/2011	CN101596170B Trospium chloride slow-release tablet
11/23/2011	CN101579410B Medicinal composition for treating prostatauxe
11/23/2011	CN101574510B Compound szechuan lovage rhizome and safflower soup used for treating thromboangitis obliterans
11/23/2011	CN101554465B Traditional Chinese medicine for curing intestine diarrhea
11/23/2011	CN101554370B Syringin for injection, preparation method and application thereof
11/23/2011	CN101543569B Donkey-hide glue nourishing ointment and preparing method thereof
11/23/2011	CN101485873B Tonic and intestine-benefiting Chinese herbal compound preparation
11/23/2011	CN101444611B Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof
11/23/2011	CN101444485B Gemcitabine liposome and preparation method thereof
11/23/2011	CN101357158B External medicine for treating summer diarrhea and preparation method thereof
11/23/2011	CN101352415B Dosage form and preparation method of acebrophylline oral solution
11/23/2011	CN101347495B Preparation of Glabridin dispersible tablets and use of the tablets in reducing blood sugar as medicament active composition
11/23/2011	CN101347414B Divisible galenical preparation form capable of controlling release of active ingredient
11/23/2011	CN101306182B Elemene vein emulsion injection and preparation method thereof
11/23/2011	CN101301369B Medicament for treating cervical vertebra and/or lumbar diseases
11/23/2011	CN101293034B Medicament composition for treating otitis medium and preparation thereof
11/23/2011	CN101264088B Antibiotics composition with stable content and rapid solubility
11/23/2011	CN101249150B Medicament for curing cervical vertebra and lumbar disease
11/23/2011	CN101244202B Chinese medicine oral administration solid preparations, preparation, quality control method and uses thereof
11/23/2011	CN101224241B Melanin regeneration pill
11/23/2011	CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
11/23/2011	CN101108243B Method of preparing traditional chinese medicine formulated product for treating rheumatism paralysis
11/23/2011	CN101107270B Method of cross-linking hyaluronic acid with divinylsulfone
11/23/2011	CN101019893B Process of enriching effective antitumor part of periplaneta americana with polyamide
11/23/2011	CN101010069B Compositions containing 5-amino-2-hydroxybenzoic acid and a reducing sugar
11/22/2011	US8063031 Implants and methods for treating inflammation-mediated conditions of the eye
11/22/2011	US8063029 Pharmaceutical composition
11/22/2011	US8063005 Personal care formulations with simultaneous exfoliant, cleansing and moisturizing properties
11/22/2011	US8062690 Dietary supplement composition for blood lipid health
11/22/2011	US8062673 Process for embolization using swellable and deformable microspheres
11/22/2011	US8062672 Antibiotic product, use and formulation thereof
11/22/2011	US8062671 Oily skin preparation for external use
11/22/2011	US8062670 mixture of non-aggregated isooctyltrimethoxysilane modified silica nanoparticle and solid bulk material in the form of a powder, containing a drug; free flowing; use in inhalation device
11/22/2011	US8062669 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof
11/22/2011	US8062668 Stimuli-responsive systems for controlled drug delivery
11/22/2011	US8062667 Modified release formulations containing drug-ion exchange resin complexes
11/22/2011	US8062666 Extended release compositions comprising as active compound venlafaxine hydrochloride
11/22/2011	US8062665 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/22/2011	US8062664 Process for preparing formulations of lipid-regulating drugs
11/22/2011	US8062663 Methods and compostions for enhancing transdermal drug delivery
11/22/2011	US8062662 Liposomes containing an entrapped compound in supersaturated solution
11/22/2011	US8062661 Methods and compositions for treating skin wounds
11/22/2011	US8062660 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
11/22/2011	US8062659 Chewable; organoleptic; partially hydrolyzed guar gum; no need for ingestion aid; compression molding
11/22/2011	US8062654 Drug releasing biodegradable fiber for delivery of therapeutics
11/22/2011	US8062652 Compositions and methods for treating precocious puberty
11/22/2011	US8062648 Formulations containing melatonin, ginkgo biloba, and biotin
11/22/2011	US8062647 High concentration baclofen preparations
11/22/2011	US8062630 Surfactant-free cosmetic, dermatological and pharmaceutical agents
11/22/2011	US8062627 Bronchodilator; side efect reduction
11/22/2011	US8062626 Ethanolic solutions; shelf life; nebulizer metering device; free of ozone damaging materials
11/22/2011	US8062607 Lens care methods and kits
11/22/2011	US8062287 Device for controlled release of chemical molecules
11/22/2011	CA2644750C Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
11/22/2011	CA2546441C Novel compounds
11/22/2011	CA2529992C Glycoside-containing liposome
11/22/2011	CA2495870C Compositions and methods for treating skin conditions
11/22/2011	CA2494762C Pharmaceutical compositions comprising cyclosporin for oral administration
11/22/2011	CA2486917C Topically applicable pharmaceutical preparation containing roflumilast
11/22/2011	CA2486007C Delivery of nucleic acid-like compounds
11/22/2011	CA2482973C Microparticles comprising carbohydrate beads covalently linked with allergen
11/22/2011	CA2461275C Compositions containing sucralose
11/22/2011	CA2456025C An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2434471C Ingestible compositions containing an odoriferous oil
11/22/2011	CA2352324C Derivatives of (-)-venlafaxine and methods of preparing and using the same
11/21/2011	CA2740507A1 Drug coated expandable devices
11/21/2011	CA2705083A1 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/20/2011	CA2704971A1 Embolizing sclerosing hydrogel
11/17/2011	WO2011143609A1 Formulations of diluted genetic material and methods for making same
11/17/2011	WO2011143566A1 Food compositions comprising organogels
11/17/2011	WO2011143559A2 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
11/17/2011	WO2011143526A2 Topical peripheral neuro-affective (tpna) therapy
11/17/2011	WO2011143484A1 A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent
11/17/2011	WO2011143479A1 Injectable parasiticidal formulations of levamisole and macrocyclic lactones
11/17/2011	WO2011143424A1 Film compositions for delivery of actives
11/17/2011	WO2011143421A1 Insulin with a stable basal release profile
11/17/2011	WO2011143347A2 Film coating composition and methods of making and using the same
11/17/2011	WO2011143296A1 Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
11/17/2011	WO2011143271A2 Therapeutic liposomes and methods for producing and using the same
11/17/2011	WO2011143254A2 Personal care formulations containing alkyl ketal esters and methods of manufacture
11/17/2011	WO2011143230A1 Methods and compositions for delivery of active agents
11/17/2011	WO2011143207A1 Synergistic antioxidant compositions
11/17/2011	WO2011143201A2 Ratiometric combinatorial drug delivery
11/17/2011	WO2011143187A2 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
11/17/2011	WO2011143128A2 Multi-phasic nanostructures for imaging and therapy
11/17/2011	WO2011143120A1 Alcoholres i stant metoprolol - containing extended - release oral dosage forms
11/17/2011	WO2011143119A1 Alcohol-resistant extended release dosage forms comprising venlafaxine
11/17/2011	WO2011143118A2 Alcohol-resistant formulations
11/17/2011	WO2011142731A2 Formulations comprising a third generation cephalosporin and clavulanic acid
11/17/2011	WO2011142730A1 Pharmaceutical composition comprising cefixime and clavulanic acid derivative compound
11/17/2011	WO2011142621A2 Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartan
11/17/2011	WO2011142515A1 Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same
11/17/2011	WO2011142504A1 Polymeric nanospheres containing hydroxybenzyl alcohol
11/17/2011	WO2011142484A1 Therapeutic agent for viral infections comprising polyalkyleneimine

1 ... 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 ... 2991